Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Hu, Yanmin ^a   Liu, Alexander ^b   Vaudrey, James ^a   Vaiciunaite, Brigita ^a   Moigboi, Christiana ^c   McTavish, Sharla M ^c   Kearns, Angela ^c   Coates, Anthony ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; FLUCLOXACILLIN; GENTAMICIN; NEOMYCIN; PENICILLIN DERIVATIVE; PLACEBO; PLECTASIN; BETA LACTAM; PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CELL MEMBRANE POTENTIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE MODEL; NEUTROPENIA; NONHUMAN; PERITONITIS; STAPHYLOCOCCUS INFECTION; ANIMAL; DRUG EFFECTS; FEMALE; MICROBIAL SENSITIVITY TEST; MOUSE; PATHOGENICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; AMOXICILLIN; ANIMALS; BETA-LACTAMS; FEMALE; GENTAMICINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PEPTIDES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84923280146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117664     Document Type: Article

References (45)

1. Toone EJ (2011) Bacterial infection remains a leading cause of death in both Western and developing world. Preface. Adv Enzymol Relat Areas Mol Biol 77: xi-xiii. PMID: 21692365
2. Arias CA, Murray BE (2009) Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 360:439-443. doi: 10.1056/NEJMp0804651 PMID: 19179312
3. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, et al. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12. doi: 10. 1086/595011 PMID: 19035777
4. Coates AR, Halls G, Hu Y (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163:184-194. doi: 10.1111/j.1476-5381.2011.01250.x PMID: 21323894
5. Fry DE, Barie PS (2011) The changing face of Staphylococcus aureus: a continuing surgical challenge. Surg Infect (Larchmt) 12:191-203. doi: 10.1089/sur.2011.068 PMID: 21812657
6. Magret M, Lisboa T, Martin-Loeches I, Manez R, Nauwynck M, et al. (2011) Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit Care 15:R62. doi: 10.1186/cc10036 PMID: 21324159
7. Hiramatsu K (2001) Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1:147-155. PMID: 11871491
8. Hill RL, Kearns AM, Nash J, North SE, Pike R, et al. (2010) Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. J Antimicrob Chemother 65:442-445. doi: 10.1093/jac/dkp494 PMID: 20089543
9. Kalan L, Wright GD (2011) Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Rev Mol Med 13:e5. doi: 10.1017/S1462399410001766 PMID: 21342612
10. Aligholi M, Emaneini M, Taherikalani M, Shahsavan S, Jabalameli F, et al. (2011) Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium. Acta Microbiol Immunol Hung 58:219-226. doi: 10.1556/AMicr. 58.2011.3.5 PMID: 21983323
11. Gordon NC, Png K, Wareham DW (2010) Potent synergy and sustained bactericidal activity of a vancomycincolistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 54:5316-5322. doi: 10.1128/AAC.00922-10 PMID: 20876375
12. Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ (2004) In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 48:753-757. PMID: 14982760
13. Elemam A, Rahimian J, Doymaz M (2010) In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J Clin Microbiol 48:3558-3562. doi: 10.1128/JCM.01106-10 PMID: 20686085
14. Hu Y, Coates AR (2012) Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies. J Antimicrob Chemother. doi: 10.1093/jac/dks475 PMID: 23264512
15. Anantharaman A, Rizvi MS, Sahal D (2010) Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides. Antimicrob Agents Chemother 54:1693-1699. doi: 10.1128/AAC.01231-09 PMID: 20176897
16. Zhang Y, Teng D, Mao R, Wang X, Xi D, et al. (2014) High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus. Appl Microbiol Biotechnol 98:681-694. doi: 10.1007/s00253-013-4881-2 PMID: 23624708
17. Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Fortuna M, et al. (2000) In vitro activities of membraneactive peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44:1716-1719. PMID: 10817738
18. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, et al. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975-980. PMID: 16222292
19. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, et al. (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328:1168-1172. doi: 10.1126/science.1185723 PMID: 20508130
20. Ostergaard C, Sandvang D, Frimodt-Moller N, Kristensen HH (2009) High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Antimicrob Agents Chemother 53:1581-1585. doi: 10.1128/AAC. 01202-08 PMID: 19188395
21. Xiong YQ, Hady WA, Deslandes A, Rey A, Fraisse L, et al. (2011) Efficacy of NZ2114, a novel plectasinderived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:5325-5330. doi: 10.1128/AAC. 00453-11 PMID: 21859940
22. Andes D, Craig W, Nielsen LA, Kristensen HH (2009) In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrob Agents Chemother 53:3003-3009. doi: 10.1128/AAC.01584-08 PMID: 19414576
23. Brinch KS, Tulkens PM, Van Bambeke F, Frimodt-Moller N, Hoiby N, et al. (2010) Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin. J Antimicrob Chemother 65:1720-1724. doi: 10. 1093/jac/dkq159 PMID: 20534628
24. Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ (1999) Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 43:335-340. PMID: 9925528
25. Chan EL, Zabransky RJ (1987) Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas. Diagn Microbiol Infect Dis 6:157-164. PMID: 3102156
26. Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez-Hernandez FJ (2011) An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci 119:245-256. doi: 10.1093/toxsci/kfq267 PMID: 20829429
27. Mazurek B, Lou X, Olze H, Haupt H, Szczepek AJ (2012) In vitro protection of auditory hair cells by salicylate from the gentamicin-induced but not neomycin-induced cell loss. Neurosci Lett 506:107-110. doi: 10.1016/j.neulet.2011.10.060 PMID: 22075224
28. Cui L, Ma X, Sato K, Okuma K, Tenover FC, et al. (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5-14. PMID: 12517819
29. Yuan W, Hu Q, Cheng H, Shang W, Liu N, et al. (2013) Cell wall thickening is associated with adaptive resistance to amikacin in methicillin-resistant Staphylococcus aureus clinical isolates. J Antimicrob Chemother 68:1089-1096. doi: 10.1093/jac/dks522 PMID: 23322605
30. Hu Y, Shamaei-Tousi A, Liu Y, Coates A (2010) A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections. PLoS One 5:e11818. doi: 10.1371/journal.pone.0011818 PMID: 20676403
31. Alborn WE Jr., Allen NE, Preston DA (1991) Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother 35:2282-2287. PMID: 1666494
32. Mascio CT, Alder JD, Silverman JA (2007) Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother 51:4255-4260. PMID: 17923487
33. Lam H, Oh DC, Cava F, Takacs CN, Clardy J, et al. (2009) D-amino acids govern stationary phase cell wall remodeling in bacteria. Science 325:1552-1555. doi: 10.1126/science.1178123 PMID: 19762646
34. Hancock RE (1981) Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J Antimicrob Chemother 8:429-445. PMID: 7037727
35. Pages JM, Sandrine AF, Mahamoud A, Bolla JM, Davin-Regli A, et al. (2010) Efflux pumps of gramnegative bacteria, a new target for new molecules. Curr Top Med Chem 10:1848-1857. PMID: 20615189
36. Zechini B, Versace I (2009) Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov 4:37-50. PMID: 19149695
37. Cottagnoud P, Cottagnoud M, Tauber MG (2003) Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob Agents Chemother 47:144-147. PMID: 12499182
38. Moellering RC Jr., Weinberg AN (1971) Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest 50:2580-2584. PMID: 5001959
39. Shahid M, Sobia F, Singh A, Malik A, Khan HM, et al. (2009) Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol 35:81-108. doi: 10.1080/10408410902733979 PMID: 19514910
40. Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8:943-950. PMID: 2532132
41. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, et al. (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442-5448. PMID: 14662923
42. Barry AL (1999) Methods for determining bactericidal activity of antimicrobial agents: approved guideline. Wayne, Pa.: [National Committee for Clinical Laboratory Standards]. xvi, 32 p. p.
43. Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. PMID: 12805255
44. Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, et al. (2006) Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis 6:55. PMID: 16545113
45. Wu M, Hancock RE (1999) Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 274:29-35. PMID: 9867806